Ellex Medical Lasers has received FDA 510(k) approval to market the Ellex 30XL laser slit lamp.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Vision- and life-threatening neuro-ophthalmological presentations
Paediatric diagnoses of juvenile idiopathic intracranial hypertension, optic neuritis and Horner syndrome
Higher Molar Dose and Its Translation into Clinical Practice
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)
According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.
Investigating causes of diplopia to minimise morbidity and mortality
Canadian investigators urged quick neuro-ophthalmologic referrals to limit the progress of life- and vision-threatening conditions
Neurotech appoints Beth Marsh as chief commercial officer ahead of US product launch
The US FDA recently approved revakinagene taroretcel-lwey (ENCELTO) for the treatment of idiopathic macular telangiectasia type 2 (MacTel)
New trends in the diagnosis of dry eye disease: A patient-centric approach
A five-step approach to personalise and simplify treatment, leading to higher efficacy